LLY

996.15

+1.15%↑

JNJ

243.81

+1.2%↑

ABBV

226.52

+0.7%↑

NVS

155.35

+0.92%↑

AZN

192.51

+0.34%↑

LLY

996.15

+1.15%↑

JNJ

243.81

+1.2%↑

ABBV

226.52

+0.7%↑

NVS

155.35

+0.92%↑

AZN

192.51

+0.34%↑

LLY

996.15

+1.15%↑

JNJ

243.81

+1.2%↑

ABBV

226.52

+0.7%↑

NVS

155.35

+0.92%↑

AZN

192.51

+0.34%↑

LLY

996.15

+1.15%↑

JNJ

243.81

+1.2%↑

ABBV

226.52

+0.7%↑

NVS

155.35

+0.92%↑

AZN

192.51

+0.34%↑

LLY

996.15

+1.15%↑

JNJ

243.81

+1.2%↑

ABBV

226.52

+0.7%↑

NVS

155.35

+0.92%↑

AZN

192.51

+0.34%↑

Home・Akciju saraksts・Microbot Medical Inc

Microbot Medical Inc

Slēgts

2.72 -4.23

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.68

Max

2.84

Galvenie mērījumi
By Trading Economics
Ienākumi	-77K -3.6M
Darbinieki	20
EBITDA	-79K -3.6M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+163.16% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 23. marts

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	24M 165M
Iepriekšējā atvēršanas cena	6.95
Iepriekšējā slēgšanas cena	2.72

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

2.52 / 2.57 Atbalsts un pretestība

Microbot Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 12. marts 23:12 UTC

Karstas akcijas

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

2026. g. 12. marts 22:15 UTC

Peļņas

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

2026. g. 12. marts 21:42 UTC

Galvenie ziņu notikumi

Stryker Says Cyberattack Disruption Is Continuing

2026. g. 12. marts 21:29 UTC

Galvenie ziņu notikumi

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

2026. g. 12. marts 21:27 UTC

Peļņas

Adobe CEO to Depart as AI Boosts Sales -- Update

2026. g. 12. marts 20:46 UTC

Peļņas

Adobe Posts Higher Sales With CEO Set to Depart

2026. g. 12. marts 20:21 UTC

Galvenie ziņu notikumi

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

2026. g. 12. marts 23:57 UTC

Tirgus saruna

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

2026. g. 12. marts 23:38 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 12. marts 23:38 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

2026. g. 12. marts 22:13 UTC

Tirgus saruna

Peļņas

Global Equities Roundup: Market Talk

2026. g. 12. marts 22:13 UTC

Tirgus saruna

Peļņas

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

2026. g. 12. marts 21:16 UTC

Iegādes, apvienošanās, pārņemšana

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

2026. g. 12. marts 21:04 UTC

Peļņas

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

2026. g. 12. marts 21:02 UTC

Peļņas

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

2026. g. 12. marts 21:02 UTC

Peļņas

Wheaton Precious Metals 4Q Sales $865M >WPM

2026. g. 12. marts 21:02 UTC

Peļņas

Wheaton Precious Metals 4Q Net $558.3M >WPM

2026. g. 12. marts 21:02 UTC

Peļņas

Wheaton Precious Metals 4Q EPS $1.23 >WPM

2026. g. 12. marts 20:57 UTC

Tirgus saruna

Galvenie ziņu notikumi

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

2026. g. 12. marts 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 12. marts 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 12. marts 20:15 UTC

Iegādes, apvienošanās, pārņemšana

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

2026. g. 12. marts 20:10 UTC

Peļņas

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

2026. g. 12. marts 20:05 UTC

Peļņas

Adobe 1Q Rev $6.4B >ADBE

2026. g. 12. marts 20:05 UTC

Peļņas

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Salīdzinājums

Cenas izmaiņa

Microbot Medical Inc Prognoze

Cenas mērķis

By TipRanks

163.16% augšup

Prognoze 12 mēnešiem

Vidējais 7.5 USD 163.16%

Augstākais 12 USD

Zemākais 5 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.52 / 2.57Atbalsts un pretestība

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.